Home » NICE Outlines Appeals Process for Drug Determinations
NICE Outlines Appeals Process for Drug Determinations
January 14, 2010
Drugmakers appealing a final appraisal determination (FAD) by the UK’s National Institute for Health and Clinical Excellence (NICE) will be allowed
to use three basic arguments, including unfair action by the institute, a draft guidance says.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor